Yaz
Yaz and your cardiovascular health
- Thu, 06/14/2012 - 3:45pm
Nexavar fails to meet endpoint goal in phase III study
- Wed, 05/23/2012 - 1:05pm
German pharmaceutical giant Bayer AG and Onyx Pharmaceuticals, Inc., announced Tuesday that Nexavar, a drug approved to treat liver and kidney cancer, failed to meet its endpoint goal in a Phase II
Bayer confirms lawsuit settlements in quarterly statement
- Tue, 05/01/2012 - 11:46am
Bayer Pharmaceuticals, a Germany based company, has confirmed in its First Quarter 2012 Stockholder’s newsletter that settlements have reached $142 million, or $218,000 per cases, for lawsuits alle
Bayer settles 500 Yaz lawsuits
- Fri, 04/27/2012 - 2:44pm
Bayer Pharmaceuticals is settling 500 Yasmin lawsuits at $220,000 per case.
FDA advisory panel under scrutiny for voting against Yaz recall
- Tue, 03/27/2012 - 11:50am
In December 2011, an advisory committee to the Food and Drug Administration (FDA) voted 15 to 11 that birth control pills Yaz and Yasmin offered more benefits than risks.
FDA advisory panel under scrutiny for voting against Yaz® recall
- Wed, 03/21/2012 - 10:34am
- Comments
Bayer settles Yaz® lawsuits
- Mon, 03/05/2012 - 11:07am
- Comments
Bayer Healthcare currently faces about 11,300 Yaz lawsuits filed by women who claim that Yaz causes serious injur
FDA advisory committee ordered to conduct new Yaz and Yasmin meeting
- Wed, 01/18/2012 - 1:23pm
- Comments
On December 8, 2011, the FDA advisory panel met to discuss the benefits and risks of birth contraceptives Yaz® and Ya
Documents reveal three FDA advisory panel members previously worked for Bayer
- Wed, 01/18/2012 - 1:12pm
- Comments
The FDA Advisory committee, which voted against a Yaz® and Yasmin® recall during December, is being questioned ab